Cyclerion Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SIREN, L.L.C. | 11/13/2025 | 116.16 K | $267.16 K | 0.00% | 3.78% |
| DRW SECURITIES, LLC | 11/14/2025 | 43.62 K | $100.32 K | 100.00% | 1.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 37.16 K | $85.49 K | 13.51% | 1.21% |
| VANGUARD GROUP INC | 11/07/2025 | 23.49 K | $54.03 K | 0.00% | 0.76% |
| BLACKROCK, INC. | 11/12/2025 | 16.80 K | $38.63 K | 0.00% | 0.55% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 13.29 K | $30.57 K | 100.00% | 0.43% |
| FMR LLC | 11/13/2025 | 4.75 K | $10.92 K | 0.13% | 0.15% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 2.33 K | $5.35 K | -15.74% | 0.08% |
| MORGAN STANLEY | 11/14/2025 | 649 | $1.49 K | 0.00% | 0.02% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 192 | $442 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 130 | $304 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 100 | $230 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 11/03/2025 | 100 | $230 | 0.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 49 | $113 | -99.50% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 22 | $50 | -8.33% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 5 | $12 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 5 | $12 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 0 | $0 | -100.00% | 0.00% |
| PANDORA WEALTH, INC. | 11/03/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclerion Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Cyclerion Therapeutics, Inc.. The most heavily invested institutionals were:
Siren, L.L.C.: 116,155
DRW Securities, LLC: 43,617
GEODE CAPITAL MANAGEMENT, LLC: 37,158
VANGUARD GROUP INC: 23,490
BlackRock, Inc.: 16,797
TWO SIGMA INVESTMENTS, LP: 13,293
8.43% of Cyclerion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 859.23 K shares in the last 24 months. This purchase volume represents approximately $2.15 M in transactions.